Esperion Therapeutis.Inc. buy daimler1
Start price
05.09.21
/
50%
€10.54
Target price
05.09.22
-
Performance (%)
1.47%
End price
19.09.21
€10.69
Summary
This prediction ended on 19.09.21 with a price of €10.69. With a performance of 1.47%, the BUY prediction by daimler1 for Esperion Therapeutis.Inc. closed with a slight gain. daimler1 has a follow-up prediction for Esperion Therapeutis.Inc. where he still thinks Esperion Therapeutis.Inc. is a Buy. daimler1 has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | 4.053% | 4.053% | 59.925% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% |
Comments by daimler1 for this prediction
In the thread Esperion Therapeutis.Inc. diskutieren
Buy Esperion Therapeutis.Inc.
In the thread Trading Esperion Therapeutis.Inc.
Current prediction by daimler1 for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.83
28.04.24
28.04.24
-
28.04.25
28.04.25
5.22%
02.05.24
02.05.24
Stopped prediction by daimler1 for Esperion Therapeutis.Inc.
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.37
11.05.23
11.05.23
-
11.05.24
11.05.24
-2.77%
15.05.23
15.05.23
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€3.09
06.02.22
06.02.22
-
06.02.23
06.02.23
8.63%
20.02.22
20.02.22